coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Healthier South Wirral PCN, Wirral (LAD) · Health Inequalities Profile

    PCN U12833 · NHS Cheshire and Merseyside Integrated Care Board · 5 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    49,912

    Registered population

    57.9% aged 18–64

    23.5%

    Aged 65+

    ICB 19.0% · England 17.9%

    4.2%

    Ethnic minority (non-White)

    1.9% Asian · England 9.6%

    18.1%

    In IMD quintile 1

    ICB 31.9% · England 21.0%

    ~9,586

    Core20 residents (est.)

    Resident basis; registered basis ~8,812 · see page 3

    8,792

    Hypertension register

    +3.09% in 3 yrs · England +5.60%

    468

    SMI register

    11.7% of Wirral (LAD)'s

    1,035

    COPD register

    Reviews -1.13% in 3 yrs

    Forecast to 2030

    9,563

    Hypertension patients, 2030

    +771 on today

    66.2%

    QRISK ≥20% on statins, 2030

    +1.96pp over 3 yrs

    6.2%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    59.4%
    Asthma and COPD annual reviews trail comparators.

    Asthma reviews sit at 59.4% (England 65.7%), leaving about 1,500 of 3,597 patients unreviewed; COPD reviews sit at 70.0% (England 76.4%).

    64.4%
    Under-80 blood pressure and lipid therapy lag.

    Despite 90.8% recent blood pressure recording, under-80 control is 64.4% (England 67.8%) and QRISK ≥ 20% lipid therapy is 62.0% (Wirral 65.8%).

    90.2%
    Severe mental illness physical checks outpace England.

    Blood pressure checks reached 90.2% (+10.7 pp over 2023 to 2025; England 83.4%) and BMI recording reached 85.8% (+12.0 pp; England 82.1%).

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    With 23.5% aged 65+, an older population may increase PCN chronic disease caseloads

    Healthier South Wirral PCN serves 49,912 registered patients across five practices. The population is older than benchmarks: 23.5% (11,747 patients) are aged 65+, above Wirral (20.7%), the ICB (19.0%) and England (17.9%). Working-age adults (18–64) comprise 57.9% and children (0–17) 18.6%. Usual residents are 95.8% White (Wirral 95.2%, ICB 93.0%, England 81.1%), with an ethnic minority share of 4.2% (Asian 1.9%). ONS list growth is projected at 1.5% to 2030 (Wirral 1.2%, ICB 2.3%, England 2.3%). Ethnicity reflects Census usual residents rather than GP registrations, and projection methodology remains unverified.

    Age profile

    0–1718.6%
    18–6457.9%
    65+23.5%

    65+: ICB 19.0%, England 17.9%

    Ethnicity

    White95.8%
    Asian1.9%
    Mixed1.4%
    Other0.5%
    Black0.5%

    Older people · falls rows are Wirral (LAD) local-authority (LA) data, not PCN

    MeasureLocalNorth WestEnglandPeriod
    Falls admissions, 65+, per 100,000 (Wirral LA)1,5172,0711,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)78.3%82.9%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)58.2%56.6%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Wirral LA)7531,0219552024/25
    Falls deaths, all ages, per 100,000 (Wirral LA)25.518.214.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 share is 18.1% overall but spans 37.4 pp across member practices

    Across the PCN, 18.1% of registered patients live in Core20 areas (national IMD deciles 1 and 2), below Wirral (34.8%), the ICB (31.9%) and England (21.0%). The weighted practice share is 17.7%, an unresolved 0.43 percentage point discrepancy. Practice shares span 37.4 pp: Sunlight Group Practice has 37.4% (estimated 6,487 patients), Orchard Surgery has 14.4% (estimated 1,008 patients), Eastham Group Practice has 11.8% (estimated 1,317 patients), and Civic Medical Centre and Spital Surgery record 0.0%. Prioritise Core20 resources toward Sunlight Group Practice, where patient volume is heavily concentrated.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Sunlight37.4% · 6,487 patients
    Orchard14.4% · 1,008 patients
    Eastham11.8% · 1,317 patients
    Civic0.0% · 0 patients
    Spital0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    468

    SMI register

    0.93% recorded prevalence

    552

    Learning disability register

    1.10% recorded prevalence

    33

    Care homes, 902 beds

    In the PCN catchment

    10.9%

    Provide unpaid care

    Wirral (LAD), Census 2021

    The PCN records 552 learning disability patients (1.1%, Wirral 0.8%, England 0.6%) and 468 severe mental illness patients (0.9%). Its catchment contains 33 care homes (902 beds). Wirral's 10.9% unpaid carer rate and 7 rough sleepers are borough figures that cannot be extrapolated. Learning disability prevalence is above Wirral and England benchmarks, so annual health checks for this cohort may represent the larger inclusion-health workload to protect.

    Severe mental illness: physical health checks

    Over 2023 to 2025, SMI blood pressure checks rose +10.7 pp (England +4.4 pp) to 90.2% and BMI checks rose +12.0 pp (England +5.1 pp) to 85.8%. Smoking cessation offers fell 2.6 pp (England +0.1 pp) to 95.4%.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    8,792

    Hypertension register

    +3.09%

    Register growth, 3 yrs

    Wirral (LAD) +6.35% · England +5.60%

    +1.33pp

    BP control, under 80

    ≤140/90 · −0.97pp aged 80+

    +771

    More patients by 2030

    Forecast 9,563 (18.65%)

    Hypertension case-finding and control

    Hypertension prevalence is 17.6% (8,792 patients), below Wirral (18.0%) but above the ICB (16.8%) and England (15.2%). Recent blood pressure checks reach 90.8% (Wirral 89.2%, ICB 88.3%, England 90.0%), yet control under age 80 lags at 64.4% against 66.5% in Wirral, 66.4% in the ICB and 67.8% nationally. For patients aged 80 and over, control fell 1.2% over 2023 to 2025 (England +2.2%) to 80.9% (Wirral 80.1%, ICB 80.0%, England 81.2%). This disparity could reflect titration delays, which clinical audit would test, though crude prevalence does not establish unmet need. Lower blood pressure control despite strong testing rates suggests prioritising medication titration and structured follow-up for patients aged under 80.

    Lipids and statins

    Patients with QRISK ≥ 20% receiving lipid-lowering therapy stand at 62.0%, below Wirral (65.8%), the ICB (63.2%) and England (63.6%), after 2023 to 2025 growth of +3.3% lagged England (+6.2%). Trailing lipid coverage relative to benchmarks may suggest reviewing primary prevention recall for high-risk patients.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 2026110,824£1.70£1.71£1.86£188,401
    Cardiovascular (all), 2025150,187£5.71£4.37£3.33£857,568

    In 2026, the PCN prescribed 110,824 lipid-regulating items at £1.70 each, below Wirral (£2.00), the ICB (£1.71) and England (£1.86), spending £17,732 less than at England's unit cost across 110,824 items. Unit cost is an expenditure indicator and does not reflect clinical appropriateness.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    −2.01%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    +2.11%

    Asthma prevalence, PCN 3-yr % change

    Asthma annual reviews fell 2.0% over 2023 to 2025 (England +4.4%) to 59.4% (England 65.7%, Wirral 63.2%, ICB 62.3%), leaving about 1,500 of 3,597 registered patients unreviewed. Second-hand smoke recording for asthmatics aged 6-19 was 67.7% (294 patients), below England (78.8%) by 11.1 percentage points. COPD reviews fell 1.1% (England +2.8%) to 70.0% (England 76.4%), while COPD prevalence fell 6.7% (England +2.6%) to 2.1% (1,035 patients; gap range -89 to +265).

    Cancer register and children's immunisation

    Cancer register prevalence is 5.3% (2,676 patients; England 3.8%, Wirral 4.8%, ICB 4.3%), growing +7.6% over 2023 to 2025 (England +9.0%). In Q1 2025/26 childhood immunisations, age-five MMR dose 1 reached 96.0% (England 91.7%), but dose 2 was 89.7% (England 82.8%), a 6.3 pp drop falling below the 95% target by 5.3 pp.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months92.0%

    England 91.0%

    6-in-1 complete primary course at 24 months94.5%

    England 92.2%

    MMR dose 1 at 24 months87.9%

    England 88.3%

    MMR dose 2 at age 589.7%

    England 82.8%

    4-in-1 pre-school booster at age 588.1%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    55.5%

    Cheshire and Merseyside ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~2,640

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Cheshire and Merseyside ICBEnglandNo usable stageStaged cancers
    Lung40.4%33.8%11%2,354
    Breast87.1%85.4%11%2,083
    Prostate52.3%53.2%12%2,037
    Bowel44.9%47.0%16%1,674
    Skin cancer86.9%87.8%21%932

    In 2022, 55.5% of cancers with known stage in NHS Cheshire and Merseyside ICB were diagnosed at stage 1 or 2 (7,482 of 13,490; England 55.3%), sitting 19.5 pp below the 75.0% national ambition by 2028. Reaching the ambition requires about 2,640 additional early diagnoses across the ICB, where known stage was recorded for 72.8% of cases (13,490 of 18,522; England 67.0%). These system-level figures describe regional pathways, not PCN performance. In Healthier South Wirral PCN, cervical screening coverage is 72.2% overall, but stands at 66.8% at Sunlight Group Practice.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In July 2026 (provisional), Wirral University Teaching Hospital NHS Foundation Trust achieved 77.6% on the 62-day cancer referral to treatment standard against the 85.0% standard (ICB 76.2%, England 71.2%). On the 28-day faster diagnosis standard, the trust reached 74.7% against the 75.0% standard (ICB 77.2%, England 79.3%). In July 2026 diagnostics, patients waiting 6+ weeks at the trust were 1.0% for non-obstetric ultrasound, 1.5% for MRI, and 1.5% for CT (England 9.9%). These figures reflect secondary care activity rather than PCN performance.

    Pathways within standard (%)WirralLiverpoolMersey and West LancashireCheshire and Merseyside ICBEngland
    28-day faster diagnosis (75%)74.7175.4772.3977.2579.32
    31-day treatment (96%)92.5390.5195.4695.7192.50
    62-day referral to treatment (85%)77.6573.2677.9676.2371.16
    Diagnostic waits over 6 weeks (%)WirralLiverpoolMersey and West LancashireEngland
    MRI1.546.4214.0421.40
    CT1.550.7113.089.92
    Echocardiography5.0712.5534.8828.48
    Colonoscopy32.8133.1418.0430.83
    Gastroscopy17.7344.9918.1729.02
    All 15 DM01 tests5.0211.5021.1723.14
    Community services activityWirral residentsCheshire and Merseyside ICB
    Care contacts58,870541,280
    Referrals13,31597,150
    Patients with a contact17,205146,240

    Community services (residents of Wirral), Jun 2026 (provisional). In June 2026, provisional community services dataset figures show that adults aged 65 and over accounted for 66.1% of all community contacts among Wirral local authority residents (38,930 of 58,870 contacts). This borough-level activity highlights substantial elderly community care use across the area, although activity is not reported at PCN level.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    GP phone access and QOF vaccination achievement vary sharply across the five practices

    Across 2025/26 QOF domains, clinical achievement remains high at 95.9% to 100.0%, but vaccination and immunisation achievement spans 71.5 pp, ranging from 28.5% at Sunlight Group Practice to 100.0% at Spital Surgery (England 55.2%). QOF overall achievement ranges from 88.5% at Sunlight Group Practice to 98.4% at Spital Surgery (England 92.5%).

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Spital Surgery1120.087.4%74.3%95.4%
    Civic1190.073.7%78.3%85.2%
    Sunlight13437.457.5%69.8%81.3%
    Eastham10411.860.5%54.9%79.9%
    Orchard Surgery10514.449.9%66.0%75.8%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNWirral (LAD)AssetPCNWirral (LAD)
    Care homes (catchment)33 (902 beds)n/aSchools (catchment)51n/a
    Children's centres416Places of worship37171
    Libraries418Primary schools (LA maintained)1252
    Primary academies936Special schoolsn/a3

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Structured asthma annual review recall

    Asthma annual reviews sit at 59.4% (Wirral 63.2%, ICB 62.3%, England 65.7%) after a -2.0% 3-year change (England +4.4%), leaving 1,461 (about 1,500) of 3,597 patients unreviewed. For discussion: practices could run single-template asthma recalls prioritising high-Core20 lists, offering flexible review slots alongside inhaler checks. Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 2

    COPD register validation and review recall

    COPD prevalence is 2.1% (1,035 patients; Wirral 2.6%, England 1.9%, gap range -89 to +265) after a -6.7% 3-year change (England +2.6%); annual reviews are 70.0% (England 76.4%). For discussion: practices could audit records for patients with repeated respiratory prescribing lacking a COPD code, alongside structured annual review recall. Moderate effort to run.

    Evidence base: the copd register is the cohort for spirometry-confirmed diagnosis, annual review and inhaler technique; register size and growth set the workload those interventions must cover.

    Policy anchor: Core20PLUS5 adults: chronic respiratory disease (COPD vaccination and exacerbation reduction); Tobacco and Vapes Bill: smokefree generation.

    Option 3

    Hypertension titration and lipid therapy review

    Hypertension prevalence is 17.6% (8,792 patients; Wirral 18.0%, England 15.2%; gap range -1,191 to +207). Under-80 BP control is 64.4% (England 67.8%) and QRISK ≥ 20% lipid therapy is 62.0% (Wirral 65.8%). Moderate effort to run.

    Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.

    Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Older adult frailty review alignment (p2)Aged 65+Neighbourhood health framework · NHS vaccination strategyPCN
    Targeted Core20 practice outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    Smoking cessation offer audit (p4)Smoking cessation support and treatment offered to patients with certain conditions (denominator incl. PCAs)MHIS · From Harm to HopePCN
    Hypertension titration and recall review (p5)Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school booster recall outreach (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Cervical screening uptake campaign (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026Practice
    Primary care telephony access review (p9)GPPS easy to contact the practice by phone10YHP, hospital to communityPractice
    Option 1 · Structured asthma annual review recall (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs)Core20PLUS5 respiratoryPCN
    Option 2 · COPD register validation and review recall (p12)COPD register · COPD: QOF prevalence · COPD patients with a review in the last 12 monthsCore20PLUS5 approach · Tobacco and Vapes BillPCN
    Option 3 · Hypertension titration and lipid therapy review (p12)Hypertension register · Hypertension: QOF prevalence · Hypertension patients with a recent BP readingCore20PLUS5 CVD · CVDPREVENT 2029PCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026Local authority2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15